Long COVID Trial, Recruiting NCT05851859 Sponsor: Centre Hospitalier Universitaire de la Réunion Condition: Long COVID
Back to Long Covid

Long COVID Trial, Recruiting

NCT05851859
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who are currently living in Reunion (the island)
  • People who have been diagnosed with Long COVID according to the World Health Organization's definition
  • People who can confirm their original COVID-19 infection and who test negative on an antigen test at the time of joining the trial

Who may not be able to join:

  • People who have a long-term or disabling breathing condition that would prevent them from doing breathing exercises (such as asthma, COPD, active tuberculosis, or lasting lung damage from COVID-19)
  • People who have regularly practised a breathing control technique — such as yoga or cardiac coherence training — in the last 6 months
  • People who are currently taking certain medications, including beta-blockers, betamimetics, anti-arrhythmic drugs, morphine, or the antidepressant Escitalopram
  • People who have a pacemaker or a serious heart condition
  • People who are currently pregnant or breastfeeding
  • People who have a diagnosed cognitive deficit (a condition affecting thinking or memory)
  • People who are under legal guardianship, have a court-appointed curator, or are under judicial protection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02 62 90 68 83

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Centre Hospitalier Universitaire de la Réunion
Registry
ClinicalTrials.gov
Start date
5 May 2025
Est. completion
1 November 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Evaluation of the effectiveness of a respiratory training to cardiac coherence on the reduction in the symptomatology of patients with Long COVID.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov